Skip to content

Clinical trials

Autism Spectrum Disorder trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Country / region: Netherlands Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20172
20181
20212
20221
20231
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Parnassia Groep3
UMC Utrecht3
Karakter Kinder- en Jeugdpsychiatrie2
Neurim Pharmaceuticals Ltd.2
Academy Het Dorp1
Erasmus Medical Center1
GGZ Friesland1
Institut de Recherches Internationales Servier1
Radboud University Medical Center1
Tilburg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder17
Autistic Disorder4
Angelman Syndrome2
Parasomnias2
Smith-Magenis Syndrome2
Tuberous Sclerosis2
Brain Injury, Chronic1
Down Syndrome1
Intellectual Disability1
Personality Disorders1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.